Nuvectis Pharma, Inc. financial statements
Nuvectis Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 26.44M | 10-K |
| Cash and equivalents | USD 31.63M | 10-Q |
Nuvectis Pharma, Inc. financials on 6ix · Nuvectis Pharma, Inc. on 6ix